{"id":"W3166073592","doi":"10.1016/s0140-6736(21)00666-8","title":"Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial","year":2021,"lang":"en","type":"article","venue":"The Lancet","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":437,"is_retracted":false,"has_abstract":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Gilead Sciences","keywords":"Medicine; Vedolizumab; Ulcerative colitis; Placebo; Internal medicine; Maintenance therapy; Clinical endpoint; Clinical trial; Gastroenterology; Regimen; Surgery; Chemotherapy; Disease; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005147106,0.0001541881,0.0003274336,0.00001779403,0.0002083582,0.00007319722,0.0001123488,0.0001066459,0.0000738709],"category_scores_gemma":[0.0002648821,0.0001007686,0.0001382252,0.00005744177,0.00008105885,0.000007637973,0.00002754203,0.0001010692,0.000005231635],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001553417,"about_ca_system_score_gemma":0.0002225817,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000007691206,"about_ca_topic_score_gemma":0.00006935112,"domain_scores_codex":[0.9988964,0.000237679,0.0002199998,0.0003001166,0.0000932625,0.0002525938],"domain_scores_gemma":[0.9992822,0.00006825319,0.000125749,0.0002690805,0.00019186,0.00006284027],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9751803,0.0001144543,0.00001316493,0.000008526962,0.0002231406,0.000008551907,0.0001025224,0.00001630817,0.01560608,0.0005058289,0.007114271,0.001106889],"study_design_scores_gemma":[0.9526221,0.0004515298,0.0001587565,0.00000890805,0.00005279278,0.00002895981,0.00008712275,0.0001175045,0.02738976,0.0005210044,0.01842105,0.0001404679],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9923661,0.0002061162,0.0005134622,0.001321983,0.0003399211,0.004033719,0.00005454587,0.00001996914,0.001144129],"genre_scores_gemma":[0.9883181,0.0004386942,0.0002075826,0.001160111,0.003109552,0.002911418,0.000175157,0.00002800726,0.00365139],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02255811,"threshold_uncertainty_score":0.4109225,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02777325386693909,"score_gpt":0.3148007038727766,"score_spread":0.2870274500058375,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}